People disfigured in accidents, war or from cancer have to wait months for an artificial nose or ear. So, a team of robotics developers at Portuguese company, μRoboptics, has stepped in to find a faster way to rebuild damaged faces with 3D printed prostheses.
It is almost a flip of a coin whether pancreatic cancer patients respond to the standard chemotherapy drug, FOLFIRINOX. As a solution to oncologists apprehensively giving patients one of the toughest chemotherapy treatments out there, Dutch bioinformatics company, Omnigen, is developing a clinical decision support system based on a DNA test that shows a patient’s responsiveness to FOLFIRINOX treatment with an initial accuracy rate of 93%.
At this year’s Global Innovation Summit in Estoril, Portugal, on 22-23 June, we presented five Eureka innovation awards to organisations for the ground-breaking products, processes or services developed during a Eureka project.
National funding bodies nominated two organisations for each of our five award categories:
People disfigured in accidents, war or from cancer have to wait months for an artificial nose or ear. So, a team of robotics developers at Portuguese company, μRoboptics, has stepped in to find a faster way to rebuild damaged faces with 3D printed prostheses.
Low earth orbit (LEO) satellites hit the news when Elon Musk offered them to Ukraine to allow residents to keep communicating with the outside world when existing telecommunications networks were knocked out. But that’s only a small illustration of what LEO satellites can do for humanity if a Korean-led research team has its way, reports Sarah Morris.
It is almost a flip of a coin whether pancreatic cancer patients respond to the standard chemotherapy drug, FOLFIRINOX. As a solution to oncologists apprehensively giving patients one of the toughest chemotherapy treatments out there, Dutch bioinformatics company, Omnigen, is developing a clinical decision support system based on a DNA test that shows a patient’s responsiveness to FOLFIRINOX treatment with an initial accuracy rate of 93%.
At this year’s Global Innovation Summit in Estoril, Portugal, on 22-23 June, we presented five Eureka innovation awards to organisations for the ground-breaking products, processes or services developed during a Eureka project.
National funding bodies nominated two organisations for each of our five award categories:
Wednesday 22 June 2022 - Ministers and their representatives, hosted by Portuguese Minister of Science, Technology and Higher Education Elvira Fortunato, gathered in Estoril for the Eureka XXVIII Ministerial Conference.
Together, they stressed the importance of Eureka in the global research, development and innovation landscape and recognised its unique role in supporting the development of ground-breaking innovations that are boosting world economies, creating jobs and have real positive societal impact.
Ministers and their representatives reaffirmed their commitment and national support to continue and further the development of Eureka.
Of particular note, Canada and South Korea became full members of Eureka. Chile was reassociated to the network.
The European Partnership on Innovative SMEs, the biggest SME-focused action in the European innovation ecosystems under the EU’s Horizon Europe, was launched by Minister Fortunato and Commission Research and Innovation Director-General Paquet.
Read the full Ministerial Conference communiqué here.
Through our funding programmes, national/regional funding bodies support SMEs, large companies, universities and research organisations conducting R&D and innovation projects together beyond borders to achieve great results.
Learn more about our programmes and discover whether we have a funding opportunity for your organisation.